Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.

shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Abstract Text:

    alexander v vlassovAlexander V Vlassov,brent korbaBrent Korba,kristine farrarKristine Farrar,sampa mukerjeeSampa Mukerjee,attila a seyhanAttila A Seyhan,heini ilvesHeini Ilves,roger l kasparRoger L Kaspar,devin leakeDevin Leake,sergei a kazakovSergei A Kazakov,brian h johnstonBrian H Johnston,

    Hepatitis C virus (HCV) is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Currently available treatment options are of limited efficacy, and there is an urgent need for development of alternative therapies. RNA interference (RNAi) is a natural mechanism by which small interfering RNA (siRNA) or short hairpin RNA (shRNA) can mediate degradation of a target RNA molecule in a sequence-specific manner. In this study, we screened in vitro-transcribed 25-bp shRNAs targeting the internal ribosome entry site (IRES) of HCV for the ability to inhibit IRES-driven gene expression in cultured cells. We identified a 44-nt region at the 3'-end of the IRES within which all shRNAs efficiently inhibited expression of an IRES-linked reporter gene. Subsequent scans within this region with 19-bp shRNAs identified even more potent molecules, providing effective inhibition at concentrations of 0.1 nM. Experiments varying features of the shRNA design showed that, for 25-bp shRNAs, neither the size of the loop (4-10 nt) nor the sequence or pairing status of the ends affects activity, whereas in the case of 19-bp shRNAs, larger loops and the presence of a 3'-UU overhang increase efficacy. A comparison of shRNAs and siRNAs targeting the same sequence revealed that shRNAs were of comparable or greater potency than the corresponding siRNAs. Anti-HCV activity was confirmed with HCV subgenomic replicons in a human hepatocyte line. The results indicate that shRNAs, which can be prepared by either transcription or chemical synthesis, may be effective agents for the control of HCV.

    shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Publishing Authors By Initials

    av vlassovAV Vlassov,b korbaB Korba,k farrarK Farrar,s mukerjeeS Mukerjee,aa seyhanAA Seyhan,h ilvesH Ilves,rl kasparRL Kaspar,d leakeD Leake,sa kazakovSA Kazakov,bh johnstonBH Johnston,

    For similar investigative techniques: genetic techniques: gene transfer techniques: transfection research abstracts see: investigative techniques: genetic techniques: gene transfer techniques: transfection research

    PUBMED ID PMID:

    MEDLINE DATE:

    shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Oligonucleotides

    VOLUME: 17

    Page Numbers: 223-36

    Journal Abbreviation:

    ISSN: 1545-4576

    DAY: 3

    MONTH: 12

    YEAR: 2007

    shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101188415

    shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Keywords Mesh Terms:

    KEYWORDS: Transfection

    MESH TERMS: genetics

    Chemical & Substance for Abstract: shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Information

    Substance Name: RNA, Viral

    Registry Number: 0

    Grant and Affiliation Information for shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.

    AFFILIATION: SomaGenics, Inc., Santa Cruz, CA 95060, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: R44AI056611

    ACRONYM: AI

    MEDLINETA: Oligonucleotides

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News